Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04857_nanopub.RABZAJbNvMGzEH6RYh-tWjXB1uDEjuXd7iwji-GoJVoPA#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB04857 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04857 label "Brasofensine [drugbank:DB04857]" assertion.
- drugbank:DB04857 seeAlso DB04857 assertion.
- drugbank:DB04857 description "Brasofensine is an orally administered dopamine reuptake inhibitor being developed for the treatment of Parkinson's Disease. Phase I/II trials for brasofensine have been completed in the U.K. In November 2001, NeuroSearch confirmed that the drug's development was discontinued in favor of NS 2230." assertion.
- drugbank:DB04857 identifier "drugbank:DB04857" assertion.
- drugbank:DB04857 title "Brasofensine" assertion.
- drugbank:DB04857 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:3846334 assertion.
- drugbank:DB04857 drugbank_vocabulary:x-pubchemcompound pubchem.compound:9554198 assertion.
- drugbank:DB04857 drugbank_vocabulary:x-chemspider chemspider:7832208 assertion.
- drugbank:DB04857 drugbank_vocabulary:x-cas cas:171655-91-7 assertion.
- drugbank:DB04857 drugbank_vocabulary:drugbank-id "DB04857" assertion.
- drugbank:DB04857 bio2rdf_vocabulary:x-identifiers.org DB04857 assertion.
- drugbank:DB04857 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04857" assertion.
- drugbank:DB04857 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04857 bio2rdf_vocabulary:identifier "DB04857" assertion.
- drugbank:DB04857 drugbank_vocabulary:x-kegg kegg:D03153 assertion.